0001562180-23-005322.txt : 20230620
0001562180-23-005322.hdr.sgml : 20230620
20230620095005
ACCESSION NUMBER: 0001562180-23-005322
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230616
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gay Jonathon
CENTRAL INDEX KEY: 0001835422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39834
FILM NUMBER: 231023760
MAIL ADDRESS:
STREET 1: 177 HUNTINGTON AVENUE, 21ST FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clene Inc.
CENTRAL INDEX KEY: 0001822791
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 852828339
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
BUSINESS PHONE: 801-676-9695
MAIL ADDRESS:
STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
FORMER COMPANY:
FORMER CONFORMED NAME: Chelsea Worldwide Inc.
DATE OF NAME CHANGE: 20200827
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-06-16
false
0001822791
Clene Inc.
CLNN
0001835422
Gay Jonathon
6550 SOUTH MILLROCK DRIVE
SUITE G50
SALT LAKE CITY
UT
84121
true
false
false
false
false
Common Stock
2023-06-16
4
P
false
105625.00
0.80
A
105625.00
I
By LLC
Common Stock
68745.00
D
Common Stock
2154848.00
I
By LLC
Warrants (Right to buy)
1.50
2023-06-16
4
A
false
105625.00
A
2023-06-16
Common Stock
105625.00
105625.00
D
Warrants (Right to buy)
1.10
2023-06-16
4
A
false
105625.00
A
2023-06-16
Common Stock
105625.00
105625.00
D
The securities are owned by Kensington CI II, LLC. Mr. Gay is a manager of and owns a minority interest in Kensington CI II, LLC. The shares owned by Kensington CI II, LLC may be deemed to be beneficially owned by Mr. Gay. Mr. Gay disclaims all shares owned by Kensington CI II, LLC for which he does not have a pecuniary or profits interest.
The securities are beneficially owned by KSV Gold, LLC. Mr. Gay is a member of KSV Gold, LLC's management team. The shares beneficially owned by KSV Gold, LLC may also be deemed to be beneficially owned by Mr. Gay. However, Mr. Gay has no control over how the shares owned by KSV Gold, LLC are voted and disclaims all shares for which he does not have a pecuniary or profits interest.
The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant.
Kensington CI II, LLC purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche B Warrant is for 105,625 shares of Common Stock of Clene Inc. at an exercise price of $1.50 per share. The Tranche B Warrant will expire on the earlier of (a) June 16, 2030, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc. The shares owned by Kensington CI II, LLC may be deemed to be beneficially owned by Mr. Gay. Mr. Gay disclaims all shares owned by Kensington CI II, LLC for which he does not have a pecuniary or profits interest.
Kensington CI II, LLC purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche A Warrant is for 105,625 shares of Common Stock of Clene Inc. at an exercise price of $1.10 per share. The Tranche B Warrant will expire on the earlier of (a) June 16, 2026, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc. The shares owned by Kensington CI II, LLC may be deemed to be beneficially owned by Mr. Gay. Mr. Gay disclaims all shares owned by Kensington CI II, LLC for which he does not have a pecuniary or profits interest.
/s/ Jerry Miraglia POA
2023-06-20